3 Hos patienter med Parkinsons sygdom i vedvarende kombinationsbehandling med levodopa sås ingen klinisk signifikant effekt af levodopabehandlingen på rasagilin clearance.
In Parkinson's disease patients receiving chronic levodopa treatment as adjunct therapy there was no clinically significant effect of levodopa treatment on rasagiline clearance.